Stibbe advises Forbion Capital Partners

Stibbe advises Forbion Capital Partners

17.02.2012 NL law

Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.


Related experience

Our website uses cookies: third party analytics cookies to best adapt our website to your needs & cookies to enable social media functionalities. For more information on the use of cookies, please check our Privacy and Cookie Policy. Please note that you can change your cookie opt-ins at any time via your browser settings.

Privacy and Cookie Policy